Health
The Oxford vaccine dilemma – wait for a better jab, or let more people have protection? – Telegraph.co.uk
Regulator seems ready to approve a vaccine with lower efficacy rates. Will it be right giving some people lower chances of being protected?
Drug companies Sanofi and GSK also announced a delay in their Covid-19 vaccine programme on Friday, after trials showed an ‘insufficient response’ in the over-50s.
Some researchers believe the Oxford jab may actually perform better than the 62 per cent efficacy rate suggests. Nobody in the vaccine arm became seriously ill or needed hospital treatment.
Mark Woolhouse, Professor of Infectious Disease Epidemiology at the University of Edinburgh, said: I dont think we should get too hung up on the…
-
Noosa News19 hours agoHelicopter pilots saving lives, providing food and fodder in flooded outback Queensland
-
Noosa News22 hours ago’Lethal new opioids’ prompt Wide Bay pill testing call
-
General18 hours agoInternal Revenue Service starts cutting 20,000 workers
-
Noosa News18 hours agoMan killed, woman seriously injured in collision in Wongabel, Atherton Tablelands, Queensland